A tailored mobile health intervention to improve adherence and asthma control in minority adolescents

Low-income and minority children suffer disproportionately high rates of asthma moribidity.1 An important contributing factor may be higher rates of low health literacy in underserved populations,2 which is associated with poor adherence3 and health outcomes.2 To date, no tailored health literacy in...

Full description

Saved in:

Bibliographic Details
Published in:	The journal of allergy and clinical immunology in practice (Cambridge, MA) Vol. 3; no. 2; pp. 288 - 290.e1
Main Authors:	Mosnaim, Giselle, MD, MS, Li, Hong, PhD, Martin, Molly, MD, MAPP, Richardson, DeJuran, PhD, Belice, Paula Jo, MS, Avery, Elizabeth, MSPH, Silberstein, Agustina, MD, Leigh, Jason, PhD, Kenyon, Robert, PhD, Jones, Steve, PhD, Bender, Bruce, PhD, Powell, Lynda H., PhD
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-03-2015 Elsevier Limited
Subjects:	Achievement tests ACT assessment Adolescent Adrenal Cortex Hormones - therapeutic use Allergy and Immunology Anti-Asthmatic Agents - therapeutic use Asthma Asthma - drug therapy Cellular telephones Child Health education Humans Internal Medicine Medication Adherence Minority Groups Mobile Applications Smartphone Smartphones Telemedicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Low-income and minority children suffer disproportionately high rates of asthma moribidity.1 An important contributing factor may be higher rates of low health literacy in underserved populations,2 which is associated with poor adherence3 and health outcomes.2 To date, no tailored health literacy intervention has demonstrated objective improvement in adherence to inhaled corticosteroids (ICS) and asthma control in underserved African American adolescents. For the duration of their participation in this research, all participants received a smartphone (HTC One V, Virgin Mobile USA, Warren, NJ) with an unlimited texting, talking, and data plan (Virgin Mobile USA); ICS (fluticasone propionate HFA MDI 110 [micro]g inhalation aerosol) and short-acting beta2-agonist (SABA) (albuterol sulfate HFA MDI 90 [micro]g inhalation aerosol) medications (provided by GlaxoSmithKline, Research Triangle Park, NC) fitted with M-ADEPT electronic medication monitors; and the M-ADEPT asthma application loaded onto their study smartphones.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	2213-2198 2213-2201
DOI:	10.1016/j.jaip.2014.10.011